2017-02-07 13:02:49 UTC

Tools for Management of C. Diff in IBD

Feb. 9, 2017

AGA Clinical Practice Update, patient guide and community discussion will help you in the treatment of C. diff in IBD.

The latest AGA Clinical Practice Update (CPU) is on the management of Clostridium difficile, or C. diff, infection in inflammatory bowel disease (IBD) patients and provides direction from the AGA CPU Committee for the management of patients with both. You can read the expert review in Clinical Gastroenterology and Hepatology.

  • For you: Andrea Shin, MD, started a discussion and poll in the AGA Community forum to test your knowledge on how to treat C. diff in IBD, using the CPU best-practice advice. Dr. Shin shared the multiple-choice case question in the forum and will provide the correct answer with explanation when the poll closes on Tuesday, Feb. 14.
  • For your patients: In connection with the CPU, AGA created a guide to share with your IBD patients to help them better understand treatment options if they have been diagnosed with C. diff.

Following the poll, the discussion will open as an eQ&A session for your questions and concerns around treating C. diff infection in IBD patients. Take the poll today and then bring your questions to Dr. Shin.

More on Clostridium difficile infection

Study Finds C. Diff Infections on the Rise, FMT Most Promising Treatment

July 5, 2017

AGA is tracking outcomes of fecal microbiota transplantation through an observational registry.

Connecting the Dots Between Antibiotics, Diet and the Gut Microbiome

June 27, 2017

AGA expert Dr. Eugene Chang spoke to U.S. News & World Report about how antibiotics alter the gut microbiome and the role of diet in restoring gut health.

Timely Use of Probiotics in Hospitalized Adults Prevents Clostridium difficile Infection: A Systematic Review With Meta-Regression Analysis

June 1, 2017

We performed an updated systematic review to help guide clinical practice.